Literature DB >> 27231156

Cystic Lung Disease Among Patients With Sjögren Syndrome: Frequency, Natural History, and Associated Risk Factors.

Carlos D Martínez-Balzano1, Sunkaru Touray2, Scott Kopec2.   

Abstract

BACKGROUND: Cystic lung disease (CLD) in Sjögren syndrome (SS) is a condition with unclear prognostic implications. Our objectives in this study are to determine its frequency, progression over time, and associated risk factors and complications.
METHODS: Eighty-four patients with primary or secondary SS and chest imaging, chest radiograph, or CT scan were retrospectively evaluated for CLD. Thirteen patients with cysts were found. Baseline characteristics of all patients were collected. A multivariate logistic regression model was used to look for predictors of CLD in patients with CT scan. Additional imaging, SS activity, and complications from CLD and SS were collected for the patients with cysts.
RESULTS: CLD had a frequency of 15.4% for all patients with chest imaging. Not all cysts were evident on radiography, and CLD frequency was 30.9% for the patients with chest CT scan. Six patients had cysts without other radiographic findings. CLD was associated with older age (OR, 1.1; 95% CI, 1.0-1.16), a diagnosis of secondary SS (OR, 12.1; 95% CI, 1.12-130.4), and seropositivity for anti-SS-related antigen A/Ro autoantibodies (OR, 26.9; 95% CI, 1.44-93.61). There was no radiologic progression of CLD for 12 patients after a 4-year median follow-up. Lung function did not exhibit temporal worsening. CLD did not correlate with a specific pattern in pulmonary function testing. Two patients had secondary infectious complications of the cysts.
CONCLUSIONS: CLD is a relatively common condition in SS that does not progress on serial radiologic and lung function follow-up. CLD, without other radiographic findings, may represent a direct manifestation of SS.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Sjögren syndrome; interstitial lung disease; pulmonary cysts; respiratory function tests; rheumatology

Mesh:

Substances:

Year:  2016        PMID: 27231156     DOI: 10.1016/j.chest.2016.05.015

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

Review 1.  A patient with primary Sjogren's syndrome, cystic lung disease, and MALT lymphoma treated successfully with rituximab: a case-based review.

Authors:  Leanna M Wise; Daniel G Arkfeld
Journal:  Clin Rheumatol       Date:  2019-12-20       Impact factor: 2.980

Review 2.  Primary Sjögren's syndrome with diffuse cystic lung changes developed systemic lupus erythematosus: a case report and literature review.

Authors:  Xiao Liu; Hao Li; Yunhong Yin; Dedong Ma; Yiqing Qu
Journal:  Oncotarget       Date:  2017-05-23

3.  Sjögren Syndrome Complicated with Cystic Lung Disease and Pulmonary Amyloidosis.

Authors:  Koichiro Takahashi; Hironori Sadamatsu; Shinsuke Ogusu; Kazutoshi Komiya; Tomomi Nakamura; Shinya Kimura; Naoko Sueoka-Aragane
Journal:  Case Rep Rheumatol       Date:  2018-03-31

4.  Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's.

Authors:  Augustine S Lee; R Hal Scofield; Katherine Morland Hammitt; Nishant Gupta; Donald E Thomas; Teng Moua; Kamonpun Ussavarungsi; E William St Clair; Richard Meehan; Kieron Dunleavy; Matt Makara; Steven E Carsons; Nancy L Carteron
Journal:  Chest       Date:  2020-10-16       Impact factor: 9.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.